← Back to screener

CVS HEALTH Corp CVS

Rank #389 · NYSE · $115.2B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
66.7
P/E
13.8
P/B
1.52
ROE
11.0%
Op. Margin
3.8%
Debt Ratio
235%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★★☆
Good

P/E 13.8x, P/B 1.52x. Ranks in the top 21% of the universe.

Profitability ★★☆☆☆
Average

ROE 11.0%. Ranks in the top 52% of the universe.

Safety ★★☆☆☆
Weak

Debt ratio 235%. Ranks in the top 66% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★☆☆
Good

Revenue growth of 10.9% year over year. Ranks in the top 33% of the universe.

Valuation is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$98.2B$6.4B$3.7B$35.8B6.572
2012$95.8B$6.1B$3.4B$34.6B6.480
2013$107.1B$6.3B$3.5B$38.0B5.971
2014$123.1B$7.2B$3.9B$37.7B5.976
2015$126.8B$8.0B$4.6B$38.0B6.395
2016$139.4B$8.8B$4.6B$37.2B6.3149
2017$153.3B$9.5B$5.2B$36.8B6.2156
2018$177.5B$10.4B$5.3B$37.7B5.8152
2019$184.8B$9.5B$6.6B$58.2B5.2237
2020$194.6B$4.0B$-0.6B$63.9B2.1248
2021$256.8B$12.0B$6.6B$69.4B4.7232
2022$268.7B$13.9B$7.2B$75.1B5.2210
2023$292.1B$13.3B$8.0B$71.5B4.6219
2024$322.5B$8.0B$4.3B$76.5B2.5226
2025$357.8B$13.7B$8.3B$75.6B3.8235

← See the full screener